QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Campbell, J. M. Articles by Wolf, B. W. Search for Related Content PubMed PubMed Citation Articles by Campbell, J. M. Articles by Wolf, B. W.

The Journal of Nutrition Vol. 127 No. 1 January 1997, pp. 130-136
Copyright ©1997 by the American Society for Nutritional Sciences

Selected Indigestible Oligosaccharides Affect Large Bowel Mass, Cecal and Fecal Short-Chain Fatty Acids, pH and Microflora in Rats^1,2

Joy M. Campbell³, George C. Fahey Jr.⁴, and Bryan W. Wolf^*

Department of Animal Sciences and Division of Nutritional Sciences, University of Illinois, Urbana, IL 61801 and ^* Ross Products Division, Abbott Laboratories, Columbus, OH 43219

ABSTRACT

INTRODUCTION

MATERIALS AND METHODS

RESULTS

DISCUSSION

FOOTNOTES

LITERATURE CITED

---

ABSTRACT

Certain indigestible oligosaccharides may benefit gastrointestinal tract health via fermentation and proliferation of desirable bacterial species. The purpose of this study was to elucidate effects of selected oligosaccharides on cecal and fecal short-chain fatty acid (SCFA) concentration, pH, total large bowel wet weight and wall weight, and gut microbiota levels in rats. Fifty male Sprague-Dawley rats were randomly assigned to one of five treatments: 1) control diet; 2) control diet + 5% microcrystalline cellulose (5% CC); 3) control diet + 5% CC + 6% fructooligosaccharides; 4) control diet + 5% CC + 6% oligofructose; or 5) control diet + 5% CC + 6% xylooligosaccharides. The control diet consisted of (dry matter basis) 20% protein, 65% carbohydrate, 10.5% fat, vitamin and mineral mixes. The duration of the study was 14 d. The oligofructose- and fructooligosaccharide-containing diets resulted in higher cecal butyrate concentrations compared with the control, cellulose and xylooligosaccharide diets. Generally, total cecal SCFA pools were higher while pH was lower from ingesting oligosaccharide-containing diets compared with control or cellulose diets. Cecal total weight and wall weight were higher from oligosaccharide consumption, whereas colonic total wet weight was higher for rats consuming xylooligosaccharides compared with other treatments; colon wall weight was unaffected by treatments. Cecal bifidobacteria and total anaerobes were higher whereas total aerobes were lower in rats fed oligosaccharide diets compared with those fed the control diet. Cecal lactobacilli levels were unaffected by treatment. Dietary incorporation of fermentable, indigestible oligosaccharides, by providing SCFA, lowering pH, and increasing bifidobacteria, may be beneficial in improving gastrointestinal health.

Key words: oligosaccharides, short-chain fatty acids, bifidobacteria, rats.

---

INTRODUCTION

Increased interest in fermentable fiber has occurred in recent years due to the beneficial effects on the human gastrointestinal tract resulting from their consumption. Research has focused on the colon and the products of colonic fermentation, namely, the short-chain fatty acids (SCFA)⁵ acetate, butyrate and propionate. Colonocytes are purported to be sustained by SCFA derived from bacterial fermentation, with butyrate oxidation providing more than 70% of the oxygen consumed by human colonic tissue (Roediger 1980a). Limited evidence (Roediger 1980a) indicates that butyrate is the preferred energy substrate of rat colonic mucosa. Impaired utilization of SCFA has been implicated in ulcerative colitis (UC), suggesting an energy-deficient state (Roediger 1980b). Mucosal cells demonstrated an absence of butyrate oxidation, reflecting a metabolic defect in the mucosa of UC patients. Moreover, Harig et al. (1989) inferred that diversion colitis represented an inflammatory state resulting from a nutritional deficiency that may be effectively treated with enemas containing SCFA, the missing nutrients.

It may be advantageous to provide indigestible oligosaccharides as an indirect source of SCFA to the large bowel. Potential substrates include fructooligosaccharides (FOS; also called neosugar, commercial name NutraFlora®, Golden Technologies Company, Westminster, CO), oligofructose (also called fructan-based oligosaccharides; commercial name Raftilose®, Raffinerie, Brussels, Belgium), and xylooligosaccharides (XOS; commercial name Xylooligo, Suntory, Tokyo, Japan). Fructooligosaccharides, oligofructose and XOS have been shown to be indigestible by human enzymes in the small intestine, but are extensively fermented in the large bowel (Hidaka et al. 1986, Mitsuoka et al. 1987, Okazaki et al. 1990) to SCFA which can be absorbed and metabolized by the host. These oligosaccharides have been implicated in increasing the densities of bifidobacteria (Hidaka et al. 1991b, Okazaki et al. 1990) and lactobacilli (Williams et al. 1994) in the gastrointestinal tract, both of which are considered beneficial intestinal bacteria.

The purpose of this study was to evaluate the in vivo effects of selected oligosaccharides on cecal and fecal SCFA concentration, pH, total large bowel wet weight and wall weight, and concentrations of intestinal microbiota.

---

MATERIALS AND METHODS

Animal selection. Fifty male Sprague-Dawley rats (average weight, 411 ± 13 g) were purchased from Harlan Sprague Dawley (Indianapolis, IN). Prior to the experiment, the rats were fed a standard nonpurified diet. Animals were individually housed in stainless steel wire-bottom cages in an environmentally controlled room (25°C) with a 12-h light:dark cycle. Rats were given free access to water. The animal use protocol was reviewed and approved by the Laboratory Animal Care Advisory Committee of the University of Illinois.

Experimental design. Rats were randomly assigned to one of five dietary treatments (10 rats/treatment). Due to space limitations, rats were divided into two blocks of 25 rats per block representing 5 rats per treatment per block. Rats were given free access to powdered semi-elemental diets. Oligosaccharides were added to partially replace the dextrose component of the control diet. Treatments were as follows: 1) control diet; 2) control diet + 5% microcrystalline cellulose (5% CC); 3) control diet + 5% CC + 6% FOS (NutraFlora®, Golden Technologies Company); 4) control diet + 5% CC + 6% oligofructose (Raftilose®, Raffinerie); and 5) control diet + 5% CC + 6% XOS (Xylooligo 95, Suntory) (Table 1). Fructooligosaccharides are produced on a commercial basis by fermenting granulated sucrose in water with an enzyme isolated from a pure strain of Aspergillus niger. The organism produces the -fructofuranosidase (fructosyltransferase) enzyme which links additional fructose units onto the fructose end of sucrose molecules to produce 1-kestose (GF₂), nystose (GF₃), and 1^f--fructofuranosylnystose (GF₄) (Hidaka et al. 1991a). Oligofructose is produced via enzymatic hydrolysis of inulin. The hydrolysis results in a wide array of oligosaccharides such as GF₂, GF₃ and GF₄ as well as oligosaccharides containing only fructose (e.g., F₃, F₄ and F₅). Xylooligosaccharides are obtained from birch wood xylan hydrolyzed by a Trichoderma-derived xylanase enzyme. The primary components of XOS are xylobiose, xylotriose and xylotetrose. Diets were formulated to meet or exceed the nutrient requirements of rats (NRC 1995). Diets differed in energy content. The calculated metabolizable energy (ME) content of the diets was 18.09, 17.25, 16.62, 16.62 and 16.62 MJ/kg for treatments 1-5, respectively. The ME values were calculated using 16.74 kJ/g for protein and carbohydrate, 37.66 kJ/g for fat and 6.28 kJ/g (Roberfroid et al. 1993) for oligosaccharides. The duration of the study was 14 d. Food intake was determined daily while body weight was determined every 3 d.

Table 1. Ingredient composition of dietary treatments fed to rats [View Table]

Collection of samples. On d 1 through 13, rats were given free access to dietary treatments. On the eve of d 13, food was removed for 8-10 h. Following food deprivation, rats were given free access to their respective diet for 2 h and intake recorded. The starving and refeeding were done to assure procurement of an appropriate sample from the cecum and colon for analysis. Rats were killed at 3 h postprandial by placement in a CO₂ chamber. A ventral midline incision was made and the cecum and colon excised. Immediately after removal, cecum and colon with contents were weighed to determine total weight. Cecal and colonic contents were collected, pH measured using a Fisher Scientific Accumet® 1001 pH meter (Fisher Scientific, Pittsburgh, PA) with a MI-410 microcombination pH electrode probe attached (Microelectrodes, Londonderry, NH), and a 0.4-g aliquot was immediately processed for SCFA analysis. Fecal contents were considered the material (pellets) taken from the lower colon to the anus. The remaining cecal and fecal contents were immediately placed in preweighed Carey-Blair transport media to maintain an anaerobic environment (Meridian Diagnostics, Cincinnati, OH) and stored under liquid nitrogen for later microbiota enumeration. Following removal of the appropriate samples, the tissues were cleaned with water, blotted dry and weighed to determine cecal and colonic total wall weight. Stool consistency was documented daily by the investigators as formed (pelleted) or unformed.

Chemical analyses. Cecal and fecal contents were acidified with 250 g/L metaphosphoric acid using a mixture of 0.4 g sample:0.8 mL acid:2.8 mL distilled H₂O and centrifuged at 25,900 × g for 20 min. The supernatant was decanted and frozen at 20°C in microfuge tubes. Following freezing, the supernatant was thawed, centrifuged in microfuge tubes at 13,000 × g for 10 min, and analyzed for lactate concentration colorimetrically (Barker and Summerson 1941) and for SCFA concentration (acetate, propionate and butyrate) via gas chromatography (Erwin et al. 1961). Briefly, concentrations of acetate, propionate and butyrate were determined in the supernatant using a Hewlett-Packard (Wilmington, DE) 5890A Series II gas chromatograph and a glass column (180 cm × 4 mm i.d.) packed with 100 g/L SP-1200/10 g/L H₃PO₄ on 80/100 mesh Chromosorb WAW (Supelco, Bellefonte, PA). Nitrogen was used as the carrier gas with a flow rate of 75 mL/min. Oven temperature was 125°C, detector temperature was 175°C and injector temperature was 180°C.

Cecal and fecal samples stored in liquid nitrogen for microbiota enumeration were thawed at room temperature and serially diluted with dilution solution (Bryant and Burkey 1953) under a CO₂ environment. Bifidobacterium species (spp.) were enumerated from the diluted samples and inoculated onto petri dishes containing a selective and differential medium, Bifidobacterium iodoacetate medium 25 (BIM-25), in an anaerobic environment. The medium composition (g/L) is as follows: reinforced clostridial agar (BBL Microbiology Systems, Cockeyville, MD), 51; nalidixic acid, 0.02; polymyxin B sulfate, 0.0085; kanamycin sulfate, 0.05; iodoacetic acid, 0.025; and 2,3,5-triphenyltetrazolium chloride, 0.025 (Muñoa and Pares 1988). The basal agar was autoclaved and allowed to cool to 55-60°C. Filtered sterilized antibiotics, iodoacetate, and 2,3,5-triphenyltetrazolium chloride then were added. Lactobacillus spp. were enumerated from the diluted samples and inoculated onto petri dishes containing Rogosa SL agar (Difco Laboratories, Detroit, MI). The agar was prepared according to manufacturer's instructions. Total anaerobic and aerobic counts were enumerated using diluted samples according to Bryant and Robinson (1961) and Mackie et al. (1978). The composition of the medium used for total culturable counts is presented in Table 2. For total anaerobic counts, all components were mixed in a round-bottomed flask before melting in a microwave. After melting, the medium was saturated with CO₂, and the NaHCO₃ solution was added. The medium then was autoclaved for sterilization, and allowed to cool to 55-60°C. Immediately before pouring the plates under anaerobic conditions, the glucose and Na₂S-cysteine solution were added while the medium was maintained under anaerobic conditions. For aerobic counts, the total cuturable counts medium was prepared as for the anaerobic counts excluding Resazurin solution, NaHCO₃ and Na₂S-cysteine. In addition, the medium was not saturated with CO₂ and plates were poured in aerobic conditions. Counting precision of the microbiota was maximized by inoculating drops of three appropriate dilutions onto their respective plates. A repeating dispenser was used to dispense six 10-µL droplets onto the agar plates. After adsorption of the droplets, the plates were inverted and incubated at 38°C inside a cabinet in an anaerobic chamber. Colony counts were made after the respective days of incubation, and colony forming units (CFU) per gram of wet sample were calculated.

Table 2. Composition of medium used for total culturable counts [View Table]

Statistical analyses. Data were analyzed by ANOVA for a randomized complete block design according to the General Linear Models procedure of SAS (SAS 1992). Model sums of squares were separated initially into block, treatment and block × treatment effects. No block × treatment interactions were significant at the P < 0.05 level; therefore, the final model consisted of block and treatment. When significant (P < 0.05) differences were detected, individual means were compared by the least significant difference method (Carmer and Swanson 1973). Correlation data were analyzed according to the Pearson Correlation (CORR) procedure of SAS (SAS 1992).

---

RESULTS

Effects of diet on intake and body weight. Intake ranged from ~15-18 g/d with an average of 16.8 g/d and fluctuated daily. On d 2, 3, 6 and 8, significant treatment differences (P < 0.05) were noted; these may have been caused by normal intake fluctuations that have little biological importance. Initial body weights ranged from 410 to 412 g with final body weights ranging from 416 to 420 g. Body weights of rats on all treatments initially declined after feeding the experimental diets because of a change in diet (nonpurified diet vs. powdered diet). However, after 4 d, body weights began to increase over time for all treatment groups. No significant differences among groups were noted in body weight even though ME content of the diets differed.

Short-chain fatty acid concentrations and molar proportions. The addition of oligofructose resulted in higher (P < 0.05) fecal acetate concentrations compared with the other treatments, whereas propionate, butyrate and lactate were unaffected by treatment (Table 3). Although the ME intake was lower for rats fed oligosaccharide diets, the addition of oligofructose or FOS resulted in higher (P < 0.05) cecal butyrate concentrations compared with XOS, control, and cellulose treatments, whereas lactate concentration was higher (P < 0.05) for rats fed XOS. Cecal concentrations of acetate and propionate were unaffected by treatment.

Table 3. Least-squares means of short-chain fatty acids (SCFA) in fecal and cecal contents of rats fed various diets1 [View Table]

The cecal SCFA pool, expressed as µmol/cecum, was altered due to oligosaccharide treatments. The cecal pools of acetate and butyrate were higher (P < 0.05) in rats consuming oligosaccharide compared with the control and cellulose diets that provided higher ME, whereas lactate was higher (P < 0.05) in rats consuming XOS compared with the other treatments. Cecal propionate also was higher (P < 0.05) in rats consuming oligosaccharides compared with those consuming cellulose. Total cecal SCFA were dramatically higher (P < 0.05) as a result of oligosaccharide consumption, which supplied lower ME.

Total large bowel weight, wall weight and pH. Gut pH, total weight and wall weights of the colon and cecum are presented in Table 4. Total weight of the colon and cecum was higher (P < 0.05) in rats consuming the XOS-containing diet compared with the other treatments. In addition, rats fed FOS or oligofructose had a higher (P < 0.05) total cecal weight compared with rats fed the control and cellulose diets. Colonic wall weight was unaffected by treatment. Cecal wall weight was higher (P < 0.05) as a result of oligosaccharide consumption. Fecal pH was lower (P < 0.05) in rats consuming XOS compared with the other treatments. Cecal pH was dramatically lower (P < 0.05) in rats consuming XOS compared with all other treatments, and was lower (P < 0.05) in rats receiving the oligofructose and FOS treatments compared with those receiving the higher ME control and cellulose treatments. Stool consistency was formed (pelleted) throughout the study with no visible differences noted among groups.

Table 4. Colonic and cecal total and wall weights, and pH values in rats fed various diets1 [View Table]

Bacterial concentrations. Fecal bifidobacteria concentrations were greatest (P < 0.05) as a result of ingestion of XOS and were higher (P < 0.05) for rats fed FOS and cellulose compared with the higher ME control (Table 5). Lactobacillus spp. were lower (P < 0.05) in rats fed XOS or oligofructose compared with those fed cellulose. Total aerobes were lower (P < 0.05) due to ingestion of oligosaccharides compared with the control and cellulose diets, whereas total anaerobes were higher (P < 0.05) for XOS-fed rats compared with all other treatments. Total anaerobes also were higher (P < 0.05) for rats fed oligofructose compared with the control and cellulose treatments, and were higher (P < 0.05) for rats fed FOS or cellulose compared with controls. Cecal bifidobacteria demonstrated a pattern similar to that which occurred in the feces, whereas cecal lactobacilli were unaffected by treatment. Furthermore, rats consuming oligosaccharide-containing diets with lower ME had a lower (P < 0.05) concentration of total aerobes in the cecum. Rats fed xylooligosaccharides had higher (P < 0.05) cecal concentrations of total anaerobes compared with rats receiving all other treatments, whereas FOS- and oligofructose-fed rats had higher (P < 0.05) concentrations compared with rats fed the higher ME control diet.

Table 5. Least squares means of microbiota concentrations in fecal and cecal contents of rats fed various diets1 [View Table]

Correlation analysis between fecal and cecal data are presented in Table 6. Overall, fecal and cecal microbiota concentrations were correlated (r > 0.73) (P < 0.0001). Additionally, cecal and fecal pH were correlated (r = 0.54) (P < 0.0001). Concentrations of SCFA in cecal and fecal contents were not correlated.

Table 6. Correlation analysis of fecal and cecal data of rats fed various diets [View Table]

---

DISCUSSION

The oligosaccharides tested in this experiment were selected based on their potential use as ingredients in various nutritional formulas that promote gastrointestinal health via SCFA production and alterations of gut microbiota. Concerning use of cecal SCFA concentrations compared with cecal SCFA pool data, values for the cecal pool appear to be a more accurate reflection of cecal fermentation when comparing oligosaccharides of various fermentabilities. This response was noted previously by Berggren et al. (1993). Other researchers also have noted that different levels of inulin fed to rats correlated better with cecal pool than with cecal concentration of SCFA (Levrat et al. 1991, Rémésy et al. 1992). The present study demonstrated the ability of 6% oligosaccharide-containing diets to elevate the cecal total SCFA pool relative to the control and cellulose treatments with a higher ME content. Similar effects were demonstrated by Younes et al. (1995) in rats fed FOS and XOS at the 7.5% dietary level. Butyrate was higher for FOS- and oligofructose-fed rats compared with those fed XOS, with acetate being the primary SCFA followed by butyrate and propionate. While these oligosaccharides differ in their chemical composition, they probably are fermented similarly by the microbiota of rats because of the presence of similar constituents (glucose and fructose) for fermentation. However, butyrate (mmol/L) was produced in a higher concentration when rats were fed the FOS and oligofructose diets compared with the XOS, control, and cellulose diets. Furthermore, butyrate, expressed as µmol/cecum, was higher when rats were fed the lower ME oligosaccharide diets compared with the higher ME control and cellulose diets. This would be anticipated due to the higher amount of available fermentable fiber provided by the oligosaccharide diets. By producing a greater concentration of butyrate, the preferred energy source for colonocytes, a trophic effect may result within the gastrointestinal tract. The diets used in the present study were semi-elemental; thus, they were more highly digestible. Therefore, the amount of undigested substrate reaching the large bowel would be lower, allowing less available substrate for fermentation that may lead to atrophy of the large bowel. However, the greater total SCFA production from the fermentable fiber may result in a decrease in mucosal atrophy by normalizing cell proliferation in the mucosa. In vivo studies with rats have documented the trophic effects of SCFA on epithelial cell proliferation (Frankel et al. 1994, Koruda et al. 1988, Kripke et al. 1989).

The elevation noted in cecal total weight and wall weight with the oligosaccharide diets may result from SCFA normalizing cell proliferation. Other researchers have demonstrated higher cecal weight and cecal wall weight caused by FOS and XOS compared with a diet with no fiber (Younes et al. 1995). Perhaps FOS and XOS increase crypt depth and cell density by providing butyrate as an energy source, resulting in higher intestinal wall weight compared with controls. When comparing differences in cecal and colonic total weights among treatments, only major differences in the former were noted. This is probably the reverse of what would be expected in humans. This discrepancy may result from the fact that rats are cecal fermentors and humans are colonic fermentors. Thus, in rats, the cecum would have the highest level of SCFA available for absorption/utilization. The acidic cecal pH resulting from ingestion of the oligosaccharide diets probably is caused by the greater level of total SCFA production. The more pronounced lower pH for rats consuming the XOS diet is likely related to the higher production of lactate.

The higher number of cecal Bifidobacterium spp. observed in rats whose diets were supplemented with lower ME oligosaccharides is in agreement with the work of several other research groups (Gibson et al. 1995, Hidaka et al. 1986 and 1991b, Mitsuoka 1990, Mitsuoka et al. 1987, Okazaki et al. 1990). The higher number of bifidobacteria and total anaerobes with a concomitant lowering in total aerobes suggests a shift towards anaerobic bacterial species in the large intestine. The XOS diet resulted in the most pronounced elevation in bifidobacteria. Okazaki et al. (1990) indicate that XOS actively support the growth of bifidobacteria, while not being utilized by other bacteria in the large intestine. Moreover, the primary end-products of Bifidobacterium spp. during fermentation are acetate and lactate. Thus, the higher lactate noted in rats fed the XOS diet may be a result of the unique fermentation pattern of bifidobacteria. Additionally, the cellulose diet elicited effects similar to those of the FOS diet in fecal bifidobacteria, lactobacilli and total anaerobes, whereas in the cecum, the cellulose diet was intermediate between the control, FOS and oligofructose diets. The effects of the cellulose diet remain unclear; however, this may be a result of rats having a longer transit time when fed the cellulose diet, allowing for increased fermentation of cellulose to elicit a similar microflora pattern as highly fermentable FOS.

The higher Bifidobacterium spp. population may result in changes in the microbial ecology of the colon that are detrimental to other anaerobic bacterial species (Gibson and Wang 1994). Oligofructose, commercially known as Raftilose® (Raffinerie), and inulin, commercially known as Raftiline® (Raffinerie), fed at 15 g/d to human subjects led to significant increases in bifidobacteria and decreases in potential pathogens (Gibson et al. 1995). The accepted mechanism by which Bifidobacterium spp. are thought to be inhibitory is related to the higher production of acetic and lactic acids during fermentation of FOS, oligofructose and XOS. Increased acid production results in a lower pH which prevents enteric colonization of potentially pathogenic microorganisms and growth of putrefactive bacteria (Gibson and Roberfroid 1995). However, Gibson and Wang (1994) indicated that acidity may not be the sole mechanism of inhibition. In a batch culture system held at pH 7, Bifidobacterium spp. were able to inhibit growth of Escherichia coli and Clostridium perfringens. Gibson and Wang (1994) theorized that bifidobacteria may be able to exert an inhibitory effect not necessarily related to acid production. In addition, May et al. (1994) showed that high SCFA levels inhibit growth of, and toxin A production by, C. difficile independent of pH. Furthermore, bifidobacteria stimulate immune function, particularly against malignant cells, produce B-complex vitamins, restore the normal intestinal flora during antibiotic therapy and reduce blood ammonia levels (Gibson and Roberfroid, 1995). Regardless of the inhibitory effect on potential pathogens, the higher amount of Bifidobacterium spp. demonstrated in the cecum of rats in the present study caused by ingestion of oligosaccharides may promote beneficial effects within the gastrointestinal tract.

The concentrations of SCFA in cecal and fecal contents were not correlated, which would be expected because SCFA are rapidly and extensively (95-99%) absorbed in the large bowel. Comparing fecal and cecal data in this experiment, it appears that changes in gut microbiota may be obtained through fecal sampling; however, to obtain meaningful SCFA and pH values, cecal samples must be collected because rats are cecal fermentors.

The data indicate that FOS, oligofructose and XOS at 6% of the diet produced higher SCFA in rats. Thus, oligosaccharides may serve as an indirect energy source for the large bowel. Furthermore, by serving as an indirect energy source for the large bowel, indigestible oligosaccharides may play a critical role in maintaining mucosal cell differentiation and, therefore, integrity of the gastrointestinal mucosa. These oligosaccharides are preferentially fermented by Bifidobacterium spp. which may be useful in promoting gastrointestinal health via restoration of normal flora following antibiotic therapy, preventing colonization of potential pathogens by lowering pH, and enhancing the immune system. Thus, providing these oligosaccharides as ingredients in nutritional formulas could benefit the health of the gastrointestinal tract.

---

FOOTNOTES

¹   Presented in part at Experimental Biology 96, April 14-17, 1996, Washington, DC [Campbell, J.M., Fahey, G.C., Jr. & Wolf, B.W. (1996) Oligosaccharides affect cecal and colonic short chain fatty acids, pH, and microflora in rats. FASEB J. 10: A4461 (abs.)].
²   The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
³   Jonathan Baldwin Turner Fellow.
⁴   To whom reprint requests should be addressed.
⁵   Abbreviations used: 5% CC, 5% microcrystalline cellulose; CFU, colony forming units; FOS, fructooligosaccharides; GF₂, 1-kestose; GF₃, nystose; GF₄, 1^f--fructofuranosylnystose; ME, metabolizable energy; SCFA, short-chain fatty acids; spp., species; UC, ulcerative colitis; XOS, xylooligosaccharides.

Manuscript received 17 May 1996. Initial reviews completed 12 July 1996. Revision accepted 16 September 1996.

---

LITERATURE CITED

• Barker S. B., Summerson W. H. The colorimetric determination of lactic acid in biological material. J. Biol. Chem. 1941; 138:535-554 [Free Full Text]
• Berggren A. M., Bjorck I.M.E., Margareta E., Nyman G. L., Eggum B. O. Short-chain fatty acid content and pH in caecum of rats given various sources of carbohydrates. J. Sci. Food Agric. 1993; 63:397-406
• Bryant M. P., Burkey L. A. Cultural methods and some characteristics of some of the more numerous groups of bacteria in the bovine rumen. J. Dairy Sci. 1953; 36:205-217 [Abstract/Free Full Text]
• Bryant M. P., Robinson I. M. An improved nonselective culture medium for ruminal bacteria and its use in determining diurnal variation in numbers of bacteria in the rumen. J. Dairy Sci. 1961; 44:1446-1456 [Abstract/Free Full Text]
• Carmer S. G., Swanson M. R. An evaluation of ten pairwise multiple comparison procedures by Monte Carlo methods. J. Am. Stat. Assoc. 1973; 68:66-74
• Erwin E. S., Marco G. J., Emery E. M. Volatile fatty acid analyses of blood and rumen fluid by gas chromatography. J. Dairy Sci. 1961; 44:1768-1771 [Abstract/Free Full Text]
• Frankel W. L., Zhang W., Singh A., Klurfeld D. M., Don S., Sakata T., Modlin I., Rombeau J. L. Mediation of the trophic effects of short-chain fatty acids on the rat jejunum and colon. Gastroenterology 1994; 106:375-380 [Medline]
• Gibson G. R., Beatty E. R., Wang X., Cummings J. H. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995; 108:975-982 [Medline]
• Gibson G. R., Roberfroid M. B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 1995; 125:1401-1412
• Gibson G. R., Wang X. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J. Appl. Bacteriol. 1994; 77:412-420 [Medline]
• Harig J. M., Soergel K. H., Komorowski R. A., Wood C. M. Treatment of diversion colitis with short-chain-fatty acid irrigation. N. Engl. J. Med. 1989; 320:23-28 [Abstract]
• Hidaka H., Eida T., Takizawa T., Tokunaga T., Tashiro Y. Effects of fructooligosaccharides on intestinal flora and human health. Bifidobact. Microflora 1986; 5:37-50
• Hidaka H., Hirayama M., Yamada K. Fructooligosaccharides enzymatic preparation and biofunctions. J. Carbohydr. Chem. 1991a; 10:509-522
• Hidaka H., Tashiro Y., Eida T. Proliferation of bifidobacteria by oligosaccharides and their useful effect on human health. Bifidobact. Microflora 1991b; 10:65-79
• Koruda M. J., Rolandelli R. H., Settle R. G. Effect of parenteral nutrition supplemented with short-chain fatty acids on adaption to massive small bowel resection. Gastroenterology 1988; 95:715-720 [Medline]
• Kripke S. A., Fox A. D., Berman J. M., Settle R. G., Rombeau J. L. Stimulation of intestinal mucosal growth with intracolonic infusion of short-chain fatty acids. J. Parent. Enteral Nutr. 1989; 13:109-116 [Abstract/Free Full Text]
• Levrat M. A., Rémésy C., Demigné C. High propionic acid fermentations and mineral accumulation in the cecum of rats adapted to different levels of inulin. J. Nutr. 1991; 121:1730-1737
• Mackie R. I., Gilchrist M. C., Robberts A. M., Hannah P. E., Schwartz H. M. Microbiological and chemical changes in the rumen during the stepwise adaptation of sheep to high concentrate diets. J. Agric. Sci. (Camb.) 1978; 90:241-254
• May T., Mackie R. I., Fahey G. C. Jr., Cremin J. D., Garleb K. A. Effect of fiber source on short-chain fatty acid production and on the growth and toxin production by Clostridium difficile. Scand. J. Gastroenterol. 1994; 19:916-922
• Mitsuoka T. Bifidobacteria and their role in human health. J. Indust. Microbiol. 1990; 6:263-268
• Mitsuoka T., Hidaka H., Eida T. Effect of fructo-oligosaccharides on intestinal microflora. Die Nahrung 1987; 31:427-436 [Medline]
• Muñoa F. J., Pares R. Selective medium for isolation and enumeration of Bifidobacterium spp. Appl. Environ. Microbiol. 1988; 54:1715-1718 [Abstract/Free Full Text]
• National Research Council. (1995) Nutrient Requirements of Laboratory Animals. National Academy Press, Washington, DC.
• Okazaki M., Fujikawa S., Matsumoto N. Effect of xylooligosaccharide on the growth of bifidobacteria. Bifidobact. Microflora 1990; 9:77-86
• Rémésy C., Behr S. R., Levrat M. A., Demigné C. Fiber fermentability in the rat cecum and its physiological consequences. Nutr. Res. 1992; 12:1235-1244
• Roberfroid M., Gibson G. R., Delzenne N. The biochemistry of oligofructose, a nondigestible fiber: an approach to calculate its caloric value. Nutr. Rev. 1993; 51:137-146 [Medline]
• Roediger W.E.W. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 1980a; 21:793-798 [Abstract/Free Full Text]
• Roediger, W.E.W. (1980b) The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Lancet ii: 712-715.
• SAS Institute Inc. (1992) SAS User's Guide: Statistics, 6.10 ed. SAS Institute, Cary, NC.
• Williams C. H., Witherly S. A., Buddington R. K. Influence of dietary neosugar on selected bacterial groups of the human faecal microbiota. Micro. Ecol. Health Dis. 1994; 7:91-97
• Younes H., Garleb K., Behr S., Rémésy C., Demigné C. Fermentable fibers or oligosaccharides reduce urinary nitrogen excretion by increasing urea disposal in the rat cecum. J. Nutr. 1995; 125:1010-1016

---

0022-3166/97 $3.00 ©1997 American Society for Nutritional Sciences

This article has been cited by other articles:

				V. Van Craeyveld, K. Swennen, E. Dornez, T. Van de Wiele, M. Marzorati, W. Verstraete, Y. Delaedt, O. Onagbesan, E. Decuypere, J. Buyse, et al. Structurally Different Wheat-Derived Arabinoxylooligosaccharides Have Different Prebiotic and Fermentation Properties in Rats J. Nutr., December 1, 2008; 138(12): 2348 - 2355. [Abstract] [Full Text] [PDF]

				K. L. Swyers, A. O. Burk, T. G. Hartsock, E. M. Ungerfeld, and J. L. Shelton Effects of direct-fed microbial supplementation on digestibility and fermentation end-products in horses fed low- and high-starch concentrates J Anim Sci, October 1, 2008; 86(10): 2596 - 2608. [Abstract] [Full Text] [PDF]

				P. Biggs, C. M. Parsons, and G. C. Fahey The Effects of Several Oligosaccharides on Growth Performance, Nutrient Digestibilities, and Cecal Microbial Populations in Young Chicks Poult. Sci., November 1, 2007; 86(11): 2327 - 2336. [Abstract] [Full Text] [PDF]

				S. Lagaert, S. Van Campenhout, A. Pollet, T. M. Bourgois, J. A. Delcour, C. M. Courtin, and G. Volckaert Recombinant Expression and Characterization of a Reducing-End Xylose-Releasing Exo-Oligoxylanase from Bifidobacterium adolescentis Appl. Envir. Microbiol., August 15, 2007; 73(16): 5374 - 5377. [Abstract] [Full Text] [PDF]

				M. Roberfroid Prebiotics: The Concept Revisited J. Nutr., March 1, 2007; 137(3): 830S - 837S. [Abstract] [Full Text] [PDF]

				G. Falony, A. Vlachou, K. Verbrugghe, and L. D. Vuyst Cross-Feeding between Bifidobacterium longum BB536 and Acetate-Converting, Butyrate-Producing Colon Bacteria during Growth on Oligofructose Appl. Envir. Microbiol., December 1, 2006; 72(12): 7835 - 7841. [Abstract] [Full Text] [PDF]

				K. Yasuda, K. R. Roneker, D. D. Miller, R. M. Welch, and X. G. Lei Supplemental Dietary Inulin Affects the Bioavailability of Iron in Corn and Soybean Meal to Young Pigs J. Nutr., December 1, 2006; 136(12): 3033 - 3038. [Abstract] [Full Text] [PDF]

				V. Lesniewska, I. Rowland, P. D. Cani, A. M. Neyrinck, N. M. Delzenne, and P. J. Naughton Effect on Components of the Intestinal Microflora and Plasma Neuropeptide Levels of Feeding Lactobacillus delbrueckii, Bifidobacterium lactis, and Inulin to Adult and Elderly Rats. Appl. Envir. Microbiol., October 1, 2006; 72(10): 6533 - 6538. [Abstract] [Full Text] [PDF]

				G. Loh, M. Eberhard, R. M. Brunner, U. Hennig, S. Kuhla, B. Kleessen, and C. C. Metges Inulin Alters the Intestinal Microbiota and Short-Chain Fatty Acid Concentrations in Growing Pigs Regardless of Their Basal Diet J. Nutr., May 1, 2006; 136(5): 1198 - 1202. [Abstract] [Full Text] [PDF]

				T. He, M. G. Priebe, H. J.M. Harmsen, F. Stellaard, X. Sun, G. W. Welling, and R. J. Vonk Colonic Fermentation May Play a Role in Lactose Intolerance in Humans J. Nutr., January 1, 2006; 136(1): 58 - 63. [Abstract] [Full Text] [PDF]

				V Lesniewska, I Rowland, H. N Laerke, G Grant, and P. J Naughton Relationship between dietary-induced changes in intestinal commensal microflora and duodenojejunal myoelectric activity monitored by radiotelemetry in the rat in vivo Exp Physiol, January 1, 2006; 91(1): 229 - 237. [Abstract] [Full Text] [PDF]

				E. L. Berg, C. J. Fu, J. H. Porter, and M. S. Kerley Fructooligosaccharide supplementation in the yearling horse: Effects on fecal pH, microbial content, and volatile fatty acid concentrations J Anim Sci, July 1, 2005; 83(7): 1549 - 1553. [Abstract] [Full Text] [PDF]

				S. J. M. Ten Bruggencate, I. M. J. Bovee-Oudenhoven, M. L. G. Lettink-Wissink, and R. Van der Meer Dietary Fructooligosaccharides Increase Intestinal Permeability in Rats J. Nutr., April 1, 2005; 135(4): 837 - 842. [Abstract] [Full Text] [PDF]

				C.-K. Hsu, J.-W. Liao, Y.-C. Chung, C.-P. Hsieh, and Y.-C. Chan Xylooligosaccharides and Fructooligosaccharides Affect the Intestinal Microbiota and Precancerous Colonic Lesion Development in Rats J. Nutr., June 1, 2004; 134(6): 1523 - 1528. [Abstract] [Full Text] [PDF]

				S J M Ten Bruggencate, I M J Bovee-Oudenhoven, M L G Lettink-Wissink, M B Katan, and R Van der Meer Dietary fructo-oligosaccharides and inulin decrease resistance of rats to salmonella: protective role of calcium Gut, April 1, 2004; 53(4): 530 - 535. [Abstract] [Full Text] [PDF]

				S. J. M. Ten Bruggencate, I. M. J. Bovee-Oudenhoven, M. L. G. Lettink-Wissink, and R. Van der Meer Dietary Fructo-Oligosaccharides Dose-Dependently Increase Translocation of Salmonella in Rats J. Nutr., July 1, 2003; 133(7): 2313 - 2318. [Abstract] [Full Text] [PDF]

				J. Busserolles, E. Gueux, E. Rock, C. Demigne, A. Mazur, and Y. Rayssiguier Oligofructose Protects against the Hypertriglyceridemic and Pro-oxidative Effects of a High Fructose Diet in Rats J. Nutr., June 1, 2003; 133(6): 1903 - 1908. [Abstract] [Full Text] [PDF]

				K. S. Swanson, C. M. Grieshop, E. A. Flickinger, L. L. Bauer, J. Chow, B. W. Wolf, K. A. Garleb, and G. C. Fahey Jr Fructooligosaccharides and Lactobacillus acidophilus Modify Gut Microbial Populations, Total Tract Nutrient Digestibilities and Fecal Protein Catabolite Concentrations in Healthy Adult Dogs J. Nutr., December 1, 2002; 132(12): 3721 - 3731. [Abstract] [Full Text] [PDF]

				J. H. A. Apajalahti, H. Kettunen, A. Kettunen, W. E. Holben, P. H. Nurminen, N. Rautonen, and M. Mutanen Culture-Independent Microbial Community Analysis Reveals that Inulin in the Diet Primarily Affects Previously Unknown Bacteria in the Mouse Cecum Appl. Envir. Microbiol., October 1, 2002; 68(10): 4986 - 4995. [Abstract] [Full Text] [PDF]

				M. Verghese, D. R. Rao, C. B. Chawan, and L. Shackelford Dietary Inulin Suppresses Azoxymethane-Induced Preneoplastic Aberrant Crypt Foci in Mature Fisher 344 Rats J. Nutr., September 1, 2002; 132(9): 2804 - 2808. [Abstract] [Full Text] [PDF]

				M. Verghese, D. R. Rao, C. B. Chawan, L. L. Williams, and L. Shackelford Dietary Inulin Suppresses Azoxymethane-Induced Aberrant Crypt Foci and Colon Tumors at the Promotion Stage in Young Fisher 344 Rats J. Nutr., September 1, 2002; 132(9): 2809 - 2813. [Abstract] [Full Text] [PDF]

				T. Tsukahara, H. Koyama, M. Okada, and K. Ushida Stimulation of Butyrate Production by Gluconic Acid in Batch Culture of Pig Cecal Digesta and Identification of Butyrate-Producing Bacteria J. Nutr., August 1, 2002; 132(8): 2229 - 2234. [Abstract] [Full Text] [PDF]

				K. S. Swanson, C. M. Grieshop, E. A. Flickinger, L. L. Bauer, H.-P. Healy, K. A. Dawson, N. R. Merchen, and G. C. Fahey Jr Supplemental Fructooligosaccharides and Mannanoligosaccharides Influence Immune Function, Ileal and Total Tract Nutrient Digestibilities, Microbial Populations and Concentrations of Protein Catabolites in the Large Bowel of Dogs J. Nutr., May 1, 2002; 132(5): 980 - 989. [Abstract] [Full Text] [PDF]

				K. K. Buddington, J. B. Donahoo, and R. K. Buddington Dietary Oligofructose and Inulin Protect Mice from Enteric and Systemic Pathogens and Tumor Inducers J. Nutr., March 1, 2002; 132(3): 472 - 477. [Abstract] [Full Text] [PDF]

				Y. Kimura, Y. Nagata, C. W. Bryant, and R. K. Buddington Nondigestible Oligosaccharides Do Not Increase Accumulation of Lipid Soluble Environmental Contaminants by Mice J. Nutr., January 1, 2002; 132(1): 80 - 87. [Abstract] [Full Text] [PDF]

				D. L. Topping and P. M. Clifton Short-Chain Fatty Acids and Human Colonic Function: Roles of Resistant Starch and Nonstarch Polysaccharides Physiol Rev, July 1, 2001; 81(3): 1031 - 1064. [Abstract] [Full Text] [PDF]

				I. Wollowski, G. Rechkemmer, and B. L Pool-Zobel Protective role of probiotics and prebiotics in colon cancer Am. J. Clinical Nutrition, February 1, 2001; 73(2): 451S - 455. [Abstract] [Full Text] [PDF]

				K. E Scholz-Ahrens, G. Schaafsma, E. G. van den Heuvel, and J. Schrezenmeir Effects of prebiotics on mineral metabolism Am. J. Clinical Nutrition, February 1, 2001; 73(2): 459S - 464. [Abstract] [Full Text] [PDF]

				R. Hughes and I.R. Rowland Stimulation of apoptosis by two prebiotic chicory fructans in the rat colon Carcinogenesis, January 1, 2001; 22(1): 43 - 47. [Abstract] [Full Text] [PDF]

				P Perrin, F Pierre, Y Patry, M Champ, M Berreur, G Pradal, F Bornet, K Meflah, and J Menanteau Only fibres promoting a stable butyrate producing colonic ecosystem decrease the rate of aberrant crypt foci in rats Gut, January 1, 2001; 48(1): 53 - 61. [Abstract] [Full Text] [PDF]

				N. M. Delzenne, N. Kok, P. Deloyer, and G. Dandrifosse Dietary Fructans Modulate Polyamine Concentration in the Cecum of Rats J. Nutr., October 1, 2000; 130(10): 2456 - 2460. [Abstract] [Full Text]

				H. N. Lærke, B. B. Jensen, and S. Højsgaard In Vitro Fermentation Pattern of D-Tagatose Is Affected by Adaptation of the Microbiota from the Gastrointestinal Tract of Pigs J. Nutr., July 1, 2000; 130(7): 1772 - 1779. [Abstract] [Full Text]

				G. Le Blay, C. Michel, H. M Blottière, and C. Cherbut Prolonged Intake of Fructo-Oligosaccharides Induces a Short-Term Elevation of Lactic Acid-Producing Bacteria and a Persistent Increase in Cecal Butyrate in Rats J. Nutr., December 1, 1999; 129(12): 2231 - 2235. [Abstract] [Full Text]

				B. S. Reddy Possible Mechanisms by Which Pro- and Prebiotics Influence Colon Carcinogenesis and Tumor Growth J. Nutr., July 1, 1999; 129(7): 1478 - 1478. [Abstract] [Full Text]

				M. S Alles, R. Hartemink, S. Meyboom, J. L Harryvan, K. M. Van Laere, F. M Nagengast, and J. G. Hautvast Effect of transgalactooligosaccharides on the composition of the human intestinal microflora and on putative risk markers for colon cancer Am. J. Clinical Nutrition, May 1, 1999; 69(5): 980 - 991. [Abstract] [Full Text] [PDF]

				E. A. Trautwein, D. Rieckhoff, and H. F. Erbersdobler Dietary Inulin Lowers Plasma Cholesterol and Triacylglycerol and Alters Biliary Bile Acid Profile in Hamsters J. Nutr., November 1, 1998; 128(11): 1937 - 1943. [Abstract] [Full Text]

				M. Kim and H. K. Shin The Water-Soluble Extract of Chicory Influences Serum and Liver Lipid Concentrations, Cecal Short-Chain Fatty Acid Concentrations and Fecal Lipid Excretion in Rats J. Nutr., October 1, 1998; 128(10): 1731 - 1736. [Abstract] [Full Text]

				J. Noack, B. Kleessen, J. Proll, G. Dongowski, and M. Blaut Dietary Guar Gum and Pectin Stimulate Intestinal Microbial Polyamine Synthesis in Rats J. Nutr., August 1, 1998; 128(8): 1385 - 1391. [Abstract] [Full Text]

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Campbell, J. M. Articles by Wolf, B. W. Search for Related Content PubMed PubMed Citation Articles by Campbell, J. M. Articles by Wolf, B. W.